DYN Jun 2024 20.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:25PM EDT. Market open.
| Previous close | 10.00 |
| Open | 7.80 |
| Bid | 7.70 |
| Ask | 8.40 |
| Strike | 20.00 |
| Expiry date | 2024-06-21 |
| Day's range | 7.70 - 8.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 67 |
GlobeNewswireDyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET
WALTHAM, Mass., May 19, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced it now plans to report new efficacy and safety data from its Phase 1/2 ACHIEVE and DELIVER clinical trials on May 20, 2024, and to host a virtual event at 8:00 a.m. ET. This represents an update to Dyne’s prior guidance for the second half o
Simply Wall St.We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
Overview of Financial Performance and Future Prospects
© 2024 Yahoo. All rights reserved.